These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
182 related articles for article (PubMed ID: 35866784)
1. Metastatic rectal neuroendocrine carcinoma presenting with treatment-refractory immune thrombocytopenia: A case report and literature review. Bancheno WM; Adidam SR; Melaku MA Medicine (Baltimore); 2022 Jul; 101(29):e29616. PubMed ID: 35866784 [TBL] [Abstract][Full Text] [Related]
2. Successful eltrombopag treatment of severe refractory thrombocytopenia in chronic myelomonocytic leukemia: Two cases reports: A CARE-compliant article. Gao Y; Gong M; Zhang C; Kong X; Ma Y Medicine (Baltimore); 2017 Oct; 96(43):e8337. PubMed ID: 29069007 [TBL] [Abstract][Full Text] [Related]
3. [A case of rectal cancer with immune thrombocytopenic purpura that achieved a complete response to continued chemotherapy with eltrombopag]. Tanaka Y; Kuroda H; Honma K; Wakaki K Nihon Shokakibyo Gakkai Zasshi; 2023; 120(10):852-857. PubMed ID: 37821375 [TBL] [Abstract][Full Text] [Related]
4. Concurrent thrombotic thrombocytopenic purpura and immune thrombocytopenic purpura in a patient with metastatic neuroendocrine tumour successfully treated with rituximab-CVP. Bayraktar S; Eileen B; Shariatmadar S; Lian E BMJ Case Rep; 2010 Nov; 2010():. PubMed ID: 22798444 [TBL] [Abstract][Full Text] [Related]
5. Avatrombopag increased platelet count in a patient with chronic immune thrombocytopenia refractory to multiple lines of treatment. Lebowa W; Zdziarska J; Sacha T Blood Coagul Fibrinolysis; 2023 Jul; 34(5):327-332. PubMed ID: 37395226 [TBL] [Abstract][Full Text] [Related]
6. Primary Hepatic Neuroendocrine Carcinoma with Thrombocytopenia Due to Diffuse Bone Marrow and Splenic Infiltration: An Autopsy Case. Nakano S; Minaga K; Tani Y; Tonomura K; Hanawa Y; Morimura H; Terashita T; Matsumoto H; Iwagami H; Nakatani Y; Akamatsu T; Uenoyama Y; Maeda C; Ono K; Watanabe T; Yamashita Y Intern Med; 2022 Nov; 61(22):3361-3368. PubMed ID: 35400708 [TBL] [Abstract][Full Text] [Related]
7. Metastatic Breast Cancer with Extensive Osseous Metastasis Presenting with Symptomatic Immune Thrombocytopenic Purpura and Anemia: A Case Report and Review of the Literature. Niu J; Goldin T; Markman M; Kundranda MN Case Rep Oncol; 2015; 8(2):256-63. PubMed ID: 26120311 [TBL] [Abstract][Full Text] [Related]
8. Immune thrombocytopenic purpura presenting in a patient after renal transplant for diabetic nephropathy. Rashid RM; Nabi Z; Ansari AZ; Qaiser QA BMC Nephrol; 2018 Mar; 19(1):69. PubMed ID: 29554892 [TBL] [Abstract][Full Text] [Related]
9. Idiopathic thrombocytopenic purpura: a 10-year natural history study at the childrens hospital of alabama. Watts RG Clin Pediatr (Phila); 2004 Oct; 43(8):691-702. PubMed ID: 15494875 [TBL] [Abstract][Full Text] [Related]
10. Severe Immune Thrombocytopenic Purpura in a Pediatric Patient With Fanconi Anemia: A Case Report. Alamri L Cureus; 2024 Sep; 16(9):e68973. PubMed ID: 39385892 [TBL] [Abstract][Full Text] [Related]
11. Rituximab for the treatment of refractory idiopathic thrombocytopenic purpura (ITP) and thrombotic thrombocytopenic purpura (TTP): report of three cases. Koulova L; Alexandrescu D; Dutcher JP; O'Boyle KP; Eapen S; Wiernik PH Am J Hematol; 2005 Jan; 78(1):49-54. PubMed ID: 15609292 [TBL] [Abstract][Full Text] [Related]
12. [Metastatic prostate cancer complicated with chronic disseminated intravascular coagulopathy causing acute renal failure, mimicking thrombotic thrombocytopenic purpura and hemolytic uremic syndrome: pathomechanism, differential diagnosis and therapy related to a case]. Deme D; Ragán M; Kalmár K; Kovács L; Varga E; Varga T; Rakonczai E Magy Onkol; 2010 Dec; 54(4):351-7. PubMed ID: 21163766 [TBL] [Abstract][Full Text] [Related]
13. Thrombocytopenia in patients with melanoma receiving immune checkpoint inhibitor therapy. Shiuan E; Beckermann KE; Ozgun A; Kelly C; McKean M; McQuade J; Thompson MA; Puzanov I; Greer JP; Rapisuwon S; Postow M; Davies MA; Eroglu Z; Johnson D J Immunother Cancer; 2017; 5():8. PubMed ID: 28239462 [TBL] [Abstract][Full Text] [Related]
14. JAK2 V617F-positive essential thrombocythemia with subsequent development of immune thrombocytopenia: A case report. Oda Y; Sato S; Kanbe E; Kamata W; Okada S; Tamai Y Medicine (Baltimore); 2019 Nov; 98(44):e17766. PubMed ID: 31689837 [TBL] [Abstract][Full Text] [Related]
17. A case of successful treatment with eltrombopag for severe immune-related thrombocytopenia induced by atezolizumab:Case report. Harada S; Imakura T; Sato S; Nokihara H; Nishioka Y J Med Invest; 2023; 70(3.4):516-520. PubMed ID: 37940542 [TBL] [Abstract][Full Text] [Related]
18. Portal vein thrombosis during eltrombopag treatment for immune thrombocytopenic purpura in a patient with liver cirrhosis due to hepatitis C viral infection. Kawano N; Hasuike S; Iwakiri H; Nakamura K; Ozono Y; Kusumoto H; Nagata K; Kikuchi I; Yoshida S; Kuriyama T; Yamashita K; Muranaka T; Kawaguchi T; Sata M; Okamura T; Ueda A; Shimoda K J Clin Exp Hematop; 2013; 53(2):151-5. PubMed ID: 23995112 [TBL] [Abstract][Full Text] [Related]
19. [Development of myelofibrosis during eltrombopag treatment in a patient with immune thrombocytopenia]. Horikoshi A; Tsukuda J; Abe R; Fujiwara N; Ito E; Takaku T Rinsho Ketsueki; 2016 May; 57(5):638-41. PubMed ID: 27263792 [TBL] [Abstract][Full Text] [Related]
20. Membranous nephropathy complicated by immune thrombocytopenia treated with low-density lipoprotein apheresis: a case report and literature review. Nishizawa K; Yamashita T; Ogawa Y; Kobayashi H CEN Case Rep; 2022 Feb; 11(1):43-49. PubMed ID: 34287815 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]